Clinical trials
Observational Renal Insufficiency trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 3 |
| University College, London | 2 |
| Barts & The London NHS Trust | 1 |
| Guerbet | 1 |
| King's College Hospital NHS Trust | 1 |
| Manchester University NHS Foundation Trust | 1 |
| Medtronic | 1 |
| Philips Healthcare | 1 |
| Portsmouth Hospitals NHS Trust | 1 |
| Ravindra Mehta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 19 |
| Heart Failure | 3 |
| Renal Insufficiency, Chronic | 3 |
| Acute Kidney Injury | 2 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus | 2 |
| Kidney Diseases | 2 |
| Myocardial Infarction | 2 |
| Proteinuria | 2 |
| Acidosis, Lactic | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.